Transgenic Plant Production
ProdiGene announces a research agreement to produce gelatin in maize
Published in Gene Therapy Weekly, July 25th, 2002
The collaboration will focus on the use of ProdiGene's proprietary transgenic plant system and FibroGen's proprietary methods for the production of a large quantity, low-cost source of FibroGen's high quality recombinant gelatin.
Concerns surrounding animal and human-derived proteins make ProdiGene's expertise in the area of recombinant protein production in plants attractive to FibroGen. ProdiGene's technologies have led to ProdiGene's previously announced scale-up to production level quantities of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-07-25)
More Articles from Gene Therapy Weekly
- Antisense Gene Therapy
Blocking integrin subunits could refine approach to cancer treatment - Liver Therapy
Vector dampens liver cell resistance to gene therapy - Lung Cancer
Certain retinoids able to override nicotine effects better than others - Ovarian Cancer
Multiple dose gene therapy yields best results in recurrent ovarian cancer - Pancreatic Cancer
Strategy utilizes fibroblast growth factor receptors for targeting cancer - Appointments
Psychiatric Genomics, Inc., names Bradley Lorimier to board of directors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
